Whether the depression of AMPK in NASH alters MKP1-mediated MAPK signaling or whether MKP1 in response to metabolic dysfunction promotes AMPK downregulation in the NAFL to NASH transition is unclear. The gene discussed is PRKAA2; the disease is metabolic dysfunction-associated steatohepatitis.